Evidence map›Paper›PMID 37139624›Full record

ArticlePharmaceutical biology2023

Protective effects of vitamin D

Rouba Yasser Al-Sroji, Shaza Al-Laham, Ahmad Almandili

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Frontiers in pharmacology · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rouba Yasser Al-SrojiDepartment of Pharmacology & Toxicology, Faculty of Pharmacy, Damascus University, Damascus, Syria.
Shaza Al-LahamDepartment of Pharmacology & Toxicology, Faculty of Pharmacy, Damascus University, Damascus, Syria.
Ahmad AlmandiliDepartment of Histopathology, Faculty of Dentistry, Damascus University, Damascus, Syria.
Damascus University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextVancomycin (VCM), an important antibiotic against refractory infections, has been used to treat secondary infections in severe COVID-19 patients. Regrettably, VCM treatment has been associated with nephrotoxicity. Vitamin D

objectiveThis study tests the antioxidant effect of vitamin D MATERIALS AND

methodsWistar Albino rats (21) were randomly divided into 3 groups: (A) control; (B) VCM 300 mg/kg daily for 1 week; and (C) VCM plus vitamin D

resultsLipid peroxidation, creatinine, and urea levels decreased significantly ( DISCUSSION AND

conclusionsVitamin D

Indexed as

CoinfectionCOVID-19AnimalsAntioxidantsCholecalciferolKidneyOxidative StressRatsRats, WistarVancomycinAntioxidantsCholecalciferolVancomycinCOVID-19creatininekidney functionlipid peroxidesnephrotoxicityoxidative stresssuperoxide dismutaseurea

Identifiers

PMID37139624
PMCPMC10161947
OpenAlexW4368359599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.